Bharat Biotech Underplays Adverse Event In Covaxin Phase 1 Trial As Start Date For Phase 3 NearsLeading Pharmaceutic… · 07:09 25 Nov 2020Bharat Biotech, during its phase 1 trials, experienced an adverse event in a volunteer that it did not promptly admit to the public. As per a statement from the vaccine maker, the event was… Read More